Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety re-evaluation of ginkgo leaf extract injection
CTR20150316Phase 4Active
- Sponsor
- Yidina
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ginkgo biloba extract in brain ischemia, stroke, brain infarction, Dementia, tinnitus, sponsored by Yidina. Started May 2015; status: active.
02
Drugs
ginkgo biloba extract
03
Conditions
brain ischemiastrokebrain infarctionDementiatinnitus
Beyond the preview
Go deeper on CTR20150316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150316.